The US FDA has given a green light to a new influenza treatment from Shionogi and Roche that has the first new mechanism of action in more than two decades.
Roche has scored two big wins with its Tecentriq cancer immunotherapy at ESMO in tough to treat triple negative breast cancer, and untreated lung cancer, as the company plays catch-up with
Novartis is preparing to file its PI3K drug combination for a certain group of breast cancer patients, after late stage trial results showed its alpelisib combination stopped the disease pr
Roche has beaten analysts’ revenue forecasts in the third quarter, after mounting sales of its older drugs in China and the success of newer drugs mitigated the impact of patent expiries.
US biotech SQZ Biotechnologies has expanded a collaboration with Roche to develop cancer therapies based on antigen presenting cells, which may be able to target solid tumours and which are
AstraZeneca will keep manufacturing investments in Britain on hold if the UK’s negotiations with Brussels fail to provide clarity on future trading relations, according to press reports.